Sponsor:
Duboce Biopharmaceuticals, Inc.
Code:
NCT07705035
Conditions
Malignant Germ Cell Tumor
Lung Adenocarcinoma
Gastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma
Urothelial Carcinoma
Endometrial Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
DBC-664
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-13. This information was provided to ClinicalTrials.gov by Duboce Biopharmaceuticals, Inc. on 2026-07-23.